About: Purposeful surgical delay and the coronavirus pandemic: how will black breast cancer patients fare?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Purposeful surgical delay and the coronavirus pandemic: how will black breast cancer patients fare? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Purposeful surgical delay and the coronavirus pandemic: how will black breast cancer patients fare?
Creator	Lustberg, Maryam Obeng-Gyasi, Samilia Oppong, Bridget Paskett, Electra
Source	Medline; PMC
abstract	PURPOSE: The Coronavirus pandemic has exposed substantial racial and ethnic health and healthcare disparities. Black breast cancer patients face significant disparities in stage of presentation, surgical management, and mortality. The objective of this editorial is to examine the possible implications of the surgical delay imposed by the pandemic on black breast cancer patients. METHODS: The American College of Surgeons, the Society of Surgical Oncology, and the American Society of Breast Surgeons recommendations for surgical delay during the Coronavirus Disease 2019 (COVID-19) were evaluated and discussed. RESULTS: Guidelines by major surgical organizations on surgical delay for breast cancer patients may inadvertently exacerbate disparities in time to surgery for black breast cancer patients. Our recommendations to better characterize the impact of these guidelines on surgical delay among vulnerable populations include the following: (1) track time from biopsy-proven diagnosis to surgery by race and ethnicity, (2) document patient and institution-related reasons for surgical delay, (3) record patient and disease-related variables/reasons for the selection of breast conservation surgery, mastectomy, and reconstruction by race and ethnicity, and (4) collect data on impactful social determinants of health such as financial reserve, housing conditions, stress, and transportation. CONCLUSIONS: The COVID-19 pandemic may exacerbate delays in time to surgery among black breast cancer patients. Surgeons should incorporate collection of social determinants of health into their clinical practice to better understand the impact of COVID-19 on racial and ethnic disparities in surgical management.
has issue date	2020-06-16(xsd:dateTime)
bibo:doi	10.1007/s10549-020-05740-0
bibo:pmid	32556796
has license	no-cc
sha1sum (hex)	e9dcdbb08f45649110f946c84d91cac0e539bef6
schema:url	https://doi.org/10.1007/s10549-020-05740-0
resource representing a document's title	Purposeful surgical delay and the coronavirus pandemic: how will black breast cancer patients fare?
has PubMed Central identifier	PMC7298443
has PubMed identifier	32556796
schema:publication	Breast Cancer Res Treat
resource representing a document's body	covid:e9dcdbb08f45649110f946c84d91cac0e539bef6#body_text
is schema:about of	named entity 'pandemic' named entity 'patients' named entity 'surgical' named entity 'pandemic' named entity 'BREAST CANCER' named entity 'BLACK' named entity 'STAGE' named entity 'PRESENTATION' named entity 'PATIENTS' named entity 'patients' named entity 'face' named entity 'breast cancer' named entity 'coronavirus pandemic' named entity 'breast cancer' named entity 'neoadjuvant chemotherapy' named entity 'COVID-19' named entity 'Louisiana' named entity 'endocrine therapy' named entity 'MGH' named entity 'surgical management' named entity 'clinical outcomes' named entity 'health disparities' named entity 'stressful times' named entity 'treatment adherence' named entity 'symptom' named entity 'COVID-19' named entity 'breast cancer' named entity 'health and healthcare' named entity 'racism' named entity 'white women' named entity 'follow-up' named entity 'doctor patient' named entity 'virus' named entity 'clinical outcomes' named entity 'hormone' named entity '2, 3' named entity 'neoadjuvant chemotherapy' named entity 'breast cancer' named entity 'genetic expression' named entity 'oncology' named entity 'coronavirus pandemic' named entity 'white women' named entity 'genomics' named entity 'social distancing' named entity 'surgical oncology' named entity 'follow-up' named entity 'comorbidities' named entity 'stratification' named entity 'healthcare providers' named entity 'breast cancer' named entity 'social workers' named entity 'breast cancer' named entity 'endocrine therapy' named entity 'virus' named entity 'Coronavirus Disease 2019' named entity 'neoadjuvant chemotherapy' named entity 'tumor size' named entity 'physical exam' named entity 'breast cancer' named entity 'public health' named entity 'surgical treatment' named entity 'mortality rates' named entity 'hormone' named entity 'paradigm' named entity 'consciousness' named entity 'COVID-19' named entity 'hormone receptor-positive breast cancer' named entity 'hormone' named entity 'SDH' named entity 'triple negative' named entity 'histology' named entity 'high-quality' named entity 'receptor' named entity 'triple negative breast cancer' named entity 'prostate' named entity 'breast cancer' named entity 'clinical outcomes' named entity 'COVID-19'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software